LU86928A1 - Mouvelles compositions pharmaceutiques a base de ketotifene - Google Patents

Mouvelles compositions pharmaceutiques a base de ketotifene Download PDF

Info

Publication number
LU86928A1
LU86928A1 LU86928A LU86928A LU86928A1 LU 86928 A1 LU86928 A1 LU 86928A1 LU 86928 A LU86928 A LU 86928A LU 86928 A LU86928 A LU 86928A LU 86928 A1 LU86928 A1 LU 86928A1
Authority
LU
Luxembourg
Prior art keywords
minutes
pharmaceutical composition
ketotifen
composition according
granule
Prior art date
Application number
LU86928A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86928A1 publication Critical patent/LU86928A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
LU86928A 1986-06-21 1987-06-19 Mouvelles compositions pharmaceutiques a base de ketotifene LU86928A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21
DE3620830 1986-06-21

Publications (1)

Publication Number Publication Date
LU86928A1 true LU86928A1 (fr) 1988-01-20

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86928A LU86928A1 (fr) 1986-06-21 1987-06-19 Mouvelles compositions pharmaceutiques a base de ketotifene

Country Status (30)

Country Link
US (1) US5399360A (nl)
JP (2) JPS638332A (nl)
KR (1) KR880000095A (nl)
AT (1) AT400521B (nl)
AU (1) AU611637B2 (nl)
BE (1) BE1000661A4 (nl)
CA (1) CA1314227C (nl)
CH (3) CH676201A5 (nl)
CY (1) CY1589A (nl)
DE (1) DE3719818C2 (nl)
DK (1) DK314387A (nl)
ES (1) ES2006170A6 (nl)
FI (1) FI872733A (nl)
FR (1) FR2600253B1 (nl)
GB (1) GB2191696B (nl)
GR (1) GR870965B (nl)
HK (1) HK27691A (nl)
HU (1) HU202753B (nl)
IE (1) IE59178B1 (nl)
IL (1) IL82924A (nl)
IT (1) IT1216822B (nl)
LU (1) LU86928A1 (nl)
MY (1) MY101566A (nl)
NL (1) NL8701335A (nl)
NO (1) NO872551L (nl)
NZ (1) NZ220769A (nl)
PH (1) PH26313A (nl)
PT (1) PT85128B (nl)
SE (1) SE8702563L (nl)
ZA (1) ZA874450B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
EP1014979A4 (en) * 1997-06-09 2003-08-20 Bridge Pharma Inc CONNECTIONS WITH COMBINED ANTIHISTAMINIC AND FAST-CELL STABILIZING ACTIVITY FOR OPHTHALMOLOGICAL USE
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
AU5139800A (en) * 1999-12-01 2001-06-12 Klein Pharmaceuticals Topical administration of ketotifen
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
CA2592605C (en) * 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2583673A1 (en) * 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
NL8502178A (nl) * 1984-08-16 1986-03-17 Sandoz Ag Nieuwe farmaceutische preparaten.
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
SE8702563L (sv) 1987-12-22
HK27691A (en) 1991-04-19
NZ220769A (en) 1990-12-21
FI872733A0 (fi) 1987-06-18
PT85128A (en) 1987-07-01
DE3719818A1 (de) 1987-12-23
AT400521B (de) 1996-01-25
FR2600253A1 (fr) 1987-12-24
FR2600253B1 (fr) 1990-01-26
BE1000661A4 (fr) 1989-03-07
SE8702563D0 (sv) 1987-06-18
ES2006170A6 (es) 1989-04-16
GB2191696A (en) 1987-12-23
CA1314227C (en) 1993-03-09
HU202753B (en) 1991-04-29
GB8714131D0 (en) 1987-07-22
ATA156187A (de) 1995-06-15
JPS638332A (ja) 1988-01-14
IT1216822B (it) 1990-03-14
DK314387A (da) 1987-12-22
CY1589A (en) 1992-04-03
CH672735A5 (nl) 1989-12-29
JPH05246849A (ja) 1993-09-24
FI872733A (fi) 1987-12-22
HUT47428A (en) 1989-03-28
DK314387D0 (da) 1987-06-19
IL82924A (en) 1992-11-15
IE59178B1 (en) 1994-01-26
PH26313A (en) 1992-04-23
NL8701335A (nl) 1988-01-18
DE3719818C2 (de) 1997-02-13
PT85128B (pt) 1990-03-30
JP2860013B2 (ja) 1999-02-24
NO872551L (no) 1987-12-22
IT8748075A0 (it) 1987-06-19
AU611637B2 (en) 1991-06-20
AU7452587A (en) 1987-12-24
IE871634L (en) 1987-12-21
KR880000095A (ko) 1988-03-23
IL82924A0 (en) 1987-12-20
US5399360A (en) 1995-03-21
GB2191696B (en) 1991-01-16
ZA874450B (en) 1989-01-25
CH674805A5 (nl) 1990-07-31
GR870965B (en) 1987-10-20
CH676201A5 (nl) 1990-12-28
MY101566A (en) 1991-12-17
NO872551D0 (no) 1987-06-18

Similar Documents

Publication Publication Date Title
LU86928A1 (fr) Mouvelles compositions pharmaceutiques a base de ketotifene
TW460282B (en) Antifungal compositions with improved bioavailability
US7741374B1 (en) Methods of use of fenofibric acid
CA2652023C (fr) Nouvelle forme d'administration du racecadotril
MX2010005680A (es) Composiciones de tapentadol.
US11890261B2 (en) Composition and method for treating neurological disease
EP1112064B1 (fr) Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
FR2766708A1 (fr) Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
AU2018326596B2 (en) High concentration dosage forms of pridopidine
RU2642962C9 (ru) Терапия болезни паркинсона с применением комбинации с фиксированными дозами
US20200129454A1 (en) Composition and method for treating neurological disease
US11833121B2 (en) Composition and method for treating neurological disease
JP5561885B2 (ja) ミルタザピンの新しい配合物
JP2005537221A (ja) トラマドールの徐放性製剤
FR2690847A1 (fr) Compositions à activité agoniste des récepteurs analogues à 5HT1 sélective.
JP4945043B2 (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤
EP1465607B1 (fr) Compositions pharmaceutiques a liberation modifiee
RU2174391C1 (ru) Фармацевтическая композиция с антидепрессантной активностью
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
RU2771522C9 (ru) Терапия болезни паркинсона с применением комбинации с фиксированными дозами
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물

Legal Events

Date Code Title Description
DT Application date
TA Annual fee